Category Archives: Salim S. Abdool Karim

  1. Antiretroviral Prophylaxis for HIV Prevention Reaches a Key Milestone

    via Lancet.com, by Salim S Abdool Karim  and Quarraisha Abdool Karim On May 10, 2012, a US Food and Drug Administration (FDA) advisory committee voted in support of the use of tenofovir-emtricitabine for HIV prevention.1 If the FDA, which is scheduled to make its decision by June 15, adopts the committee’s recommendations, tenofovir-emtricitabine will become the first Read More >>

    antiretroviral therapy, ART, ARV, ARVs, FDA, FEM-PrEP, HIV, HIV/AIDS. pre-exposure prophylaxis, pre-exposure prophylaxis, PrEP, Salim S. Abdool Karim, Treatment, Treatment as Prevention, VOICE
  2. An Interview with Professor Salim Abdool Karim about VOICE Trial Setbacks

    viaAllAfrica, interview with Professor Salim Abdool Karim Professor Salim Abdool Karim, director of the Centre for the AIDS Program of Research in South Africa (Caprisa) at the University of KwaZulu-Natal and Columbia University in the United States, spoke to AllAfrica’s Julie Frederikse about the unexpected halt of a study into tenofovir vaginal gel. This followed a finding Read More >>

    Africa, CAPRISA, Microbicides, Salim S. Abdool Karim, South Africa, VOICE
  3. No time to give up on microbicides

    via allAfrica.com, by Julie Frederikse Africans tracking the worldwide HIV epidemic have not found much to celebrate since Aids began ravaging the continent 30 years ago, but researchers are optimistic that they are learning as much from their failures as their successes. Sub-Saharan Africa still carries the biggest burden of HIV worldwide, and while there has been Read More >>

    Africa, CAPRISA, Microbicides, Salim S. Abdool Karim, South Africa, sub-saharan Africa, VOICE
  4. The Future Role of Rectal and Vaginal Microbicides in Heterosexual Couples

    via STI British Medical Journal, by Marie-Claude Boily, Dobromir Dimitrov, Salim S Abdool Karim, Benoît MâsseObjectives To compare the potential impact of rectal (RMB), vaginal (VMB) and bi-compartment (RVMB) (applied vaginally and protective during vaginal and anal intercourse) microbicides to prevent HIV in various heterosexual populations. To understand when a RMB is as useful than a VMB Read More >>

    Microbicides, rectal microbicide, Salim S. Abdool Karim, vaginal microbicide
  5. ARV gel almost ready to roll out

    via the Daily News, by Liz Clarke In the time it takes parents to see their children grow from birth to adulthood, the vaginal gel containing the antiretroviral tenofovir has been under close and intense scrutiny. Now nobody is more keen to see the fast-track roll-out of the life-saving microbicide than Professor Quarraisha Abdool Karim. Research initiated Read More >>

    CAPRISA, Microbicides, Salim S. Abdool Karim, South Africa, Tenofovir, vaginal microbicide, WHO
  6. IRMA’s next teleconference: Yes, Africa Needs Rectal Microbicides – 9/27

    Yes, Africa Needs Rectal MicrobicidesTuesday, September 27, 2011, 10:00 EDT(click here to determine the time in your area) Please join IRMA and AVAC with our special guest Dr. Salim Abdool Karim (Slim.) Slim is a clinical infectious diseases epidemiologist whose main current research interests are in microbicides and vaccines to prevent HIV infection and implementing antiretroviral therapy Read More >>

    Africa, IRMA, Project ARM, rectal microbicide, Salim S. Abdool Karim, teleconference
  7. Does Africa Need a Rectal Microbicide? The answer – YES!

    A rectal microbicide as a new HIV prevention technology is urgently needed in Africa for the large number of people practicing anal sex. Current HIV prevention efforts are unable to contain or reduce the spread of HIV infection through anal sex. One of the highlights of Microbicides 2010 was the presentation Does Africa need a rectal microbicide?  Read More >>

    Africa, anal sex, criminalization, gay men, heterosexual epidemic, human rights, LGBT rights, M2010, MSM, new prevention technologies, rectal microbicide, Salim S. Abdool Karim, stigma